{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:30:23Z","timestamp":1767972623671,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jpba.2023.115881","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T18:20:38Z","timestamp":1701368438000},"page":"115881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a chiral UPLC-MS\/MS method for quantifying S-Oxiracetam and R-Oxiracetam in human plasma, urine and feces: Application to a phase-I clinical pharmacokinetic study"],"prefix":"10.1016","volume":"239","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpba.2023.115881_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0404.1992.tb05077.x","article-title":"Oxiracetam in dementia: a double-blind, placebo-controlled study","volume":"86","author":"Bottini","year":"1992","journal-title":"Acta Neurol. Scand."},{"issue":"10","key":"10.1016\/j.jpba.2023.115881_bib2","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.035","article-title":"Bone marrow stromal cells combined with oxiracetam influences the expression of B-cell lymphoma 2 in rats with ischemic stroke","volume":"vol. 23","author":"Wang","year":"2014","journal-title":"J. Stroke Cereb. Dis."},{"issue":"1","key":"10.1016\/j.jpba.2023.115881_bib3","first-page":"44","article-title":"\u201cTreatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy\u201d","volume":"vol. 15","author":"Rozzini","year":"1993","journal-title":"Acta Neurol."},{"key":"10.1016\/j.jpba.2023.115881_bib4","unstructured":"L..Chiodini, G..Pepeu, Composition comprising S-oxiracetam for use as nootropic: WO, 9306826 (P)."},{"issue":"1","key":"10.1016\/j.jpba.2023.115881_bib5","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1038\/s41598-017-10283-4","article-title":"(S)-Oxiracetam is the active ingredient in oxiracetam that alleviates the cognitive impairment induced by chronic cerebral hypoperfusion in rats","volume":"vol. 7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2023.115881_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113072","article-title":"Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam","volume":"vol. 180","author":"Wang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115881_bib7","first-page":"9","article-title":"Enantioselective HPLC determination of oxiracetam enantiomers and application to a pharmacokinetic study in beagle dogs","volume":"vol. 993\u2013994","author":"Zhang","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.jpba.2023.115881_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-022X(02)00124-0","article-title":"The importance of stereoselective determination of drugs in the clinical laboratory","volume":"vol. 54","author":"Rentsch","year":"2002","journal-title":"J. Biochem Biophys. Methods"},{"issue":"3","key":"10.1016\/j.jpba.2023.115881_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpba.2004.07.031","article-title":"Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography\/electrospray tandem mass spectrometry","volume":"vol. 36","author":"Son","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2023.115881_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/chromsci\/bmu123","article-title":"Development and validation of a RP-HPLC method for the simultaneous determination of aceglutamide and oxiracetam in an injection formulation","volume":"vol. 53","author":"Wang","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2023.115881_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0021-9673(00)91255-X","article-title":"Direct chromatographic separation of the enantiomers of oxiracetam","volume":"508","author":"Camilleri","year":"1990","journal-title":"J. Chromatogr. A."},{"issue":"4","key":"10.1016\/j.jpba.2023.115881_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00126662","article-title":"Molecular modelling studies and the chromatographic behaviour of oxiracetam and some closely related molecules","volume":"vol. 5","author":"Camilleri","year":"1991","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jpba.2023.115881_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0021-9673(93)83363-W","article-title":"Chiral high-performance liquid chromatography of some related bicyclic lactams","volume":"654","author":"Camilleri","year":"1993","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2023.115881_bib15","unstructured":"F.D.A., Bioanalytical Method Validation Guidance for Industry, 2018. https:\/\/ www.fda.gov\/media\/70858\/download."},{"key":"10.1016\/j.jpba.2023.115881_bib16","unstructured":"I.C.H.,Bioanalytical Method Validation and Study Sample Analysis M10,2022. https:\/\/www.ich.org\/page\/multidisciplinary-guidelines."},{"key":"10.1016\/j.jpba.2023.115881_bib17","unstructured":"https:\/\/www.daicelchiraltech.cn\/column\/hplc_2\/AD-H.html."},{"key":"10.1016\/j.jpba.2023.115881_bib18","doi-asserted-by":"crossref","unstructured":"G. Pifferi, M. Pinza, Farmacol. Ed. Sci. 32 (1977) 602\u2013613B. Saletu, L. Linzmayer, J. Grunberger, H. Pietschmann, Neuropsychobiology 13 (1985) 44\u201352.","DOI":"10.1159\/000118161"},{"key":"10.1016\/j.jpba.2023.115881_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110528","article-title":"Determination of the R- and S-enantiomers of methylone andethylone in seized drugs by enantioselective liquid chromatography tandem mass spectrometry analysis","volume":"317","author":"Lin","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2023.115881_bib21","first-page":"347","article-title":"Handbook of LC-MS bioanalysis: Best Practices","author":"Li","year":"2016","journal-title":"Exp. Protocals, Regul."},{"issue":"2","key":"10.1016\/j.jpba.2023.115881_bib22","first-page":"129","article-title":"Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA","volume":"vol. 25","author":"Gross","year":"1992","journal-title":"Braz. J. Med Biol. Res"},{"issue":"6","key":"10.1016\/j.jpba.2023.115881_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13318-021-00718-9","article-title":"Pharmacokinetic properties of S-oxiracetam after single and multiple intravenous infusions in healthy volunteers","volume":"46","author":"Liang","year":"2021","journal-title":"Eur. J. Drug Metab. Pharm."},{"issue":"3","key":"10.1016\/j.jpba.2023.115881_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03189650","article-title":"Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers","volume":"9","author":"Perucca","year":"1984","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jpba.2023.115881_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpba.2015.03.039","article-title":"Comparative pharmacokinetic studies of racemic oxiracetam and its pure enantiomers after oral administration in rats by a stereoselective HPLC method","volume":"111","author":"Zhang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:32:50Z","timestamp":1760002370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523006507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S0731708523006507"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115881","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a chiral UPLC-MS\/MS method for quantifying S-Oxiracetam and R-Oxiracetam in human plasma, urine and feces: Application to a phase-I clinical pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115881"}}